Cargando…
CDK1/2/5 blockade: killing two birds with one stone
Pancreatic ductal adenocarcinoma (PDAC) is an immune resistant tumor. We recently demonstrated that inhibiting CDK1/2/5 by dinaciclib not only blocks immune checkpoint expression, but also triggers histone-dependent immunogenic cell death. This dual mechanism turns immunologically “cold” tumor micro...
Autores principales: | Liu, Jiao, Kang, Rui, Tang, Daolin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833763/ https://www.ncbi.nlm.nih.gov/pubmed/33537177 http://dx.doi.org/10.1080/2162402X.2021.1875612 |
Ejemplares similares
-
Inhibition of the mevalonate pathway to override chemoresistance and promote the immunogenic demise of cancer cells: Killing two birds with one stone
por: Riganti, Chiara, et al.
Publicado: (2013) -
Targeting HSP90 sensitizes pancreas carcinoma to PD-1 blockade
por: Liu, Jiao, et al.
Publicado: (2022) -
Killing two birds with one stone: Blocking the mitochondrial pyruvate carrier to inhibit lactate uptake by cancer cells and radiosensitize tumors
por: Linden, Catherine Vander, et al.
Publicado: (2018) -
The dark side of ferroptosis in pancreatic cancer
por: Liu, Jiao, et al.
Publicado: (2021) -
Rapamycin: Killing two birds with one stone
por: Khanna, Amit, et al.
Publicado: (2011)